Jane Theaker, MSc

Jane Theaker, MSc, is the CEO of PBD Biotech, a pioneer in the development of phage-based diagnostics for tuberculosis and related diseases.

Articles by Jane Theaker, MSc

Natural mechanisms of bacteriophages may help identify active TB early in those at risk